Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) crossed above its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of GBX 28.25 and traded as high as GBX 29. Cambridge Cognition shares last traded at GBX 29, with a volume of 77 shares.
Cambridge Cognition Trading Up 5.5%
The company has a market cap of £15.65 million, a price-to-earnings ratio of -9.35 and a beta of 0.81. The company has a quick ratio of 0.96, a current ratio of 0.41 and a debt-to-equity ratio of 10.91. The company’s 50-day moving average is GBX 28.25 and its 200 day moving average is GBX 33.93.
Cambridge Cognition (LON:COG – Get Free Report) last released its quarterly earnings data on Wednesday, September 16th. The company reported GBX (1.60) earnings per share for the quarter. Cambridge Cognition had a negative net margin of 13.86% and a negative return on equity of 54.17%. Research analysts predict that Cambridge Cognition Holdings Plc will post 1.03 EPS for the current year.
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Recommended Stories
- Five stocks we like better than Cambridge Cognition
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
